- Home
- RPID vs SEER Comparison
RPID vs SEER Comparison
Compare RPID & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPID
- SEER
- Stock Information
- Founded
- RPID 2006
- SEER 2017
- Country
- RPID United States
- SEER United States
- Employees
- RPID N/A
- SEER N/A
- Industry
- RPID Medical Specialities
- SEER Medicinal Chemicals and Botanical Products
- Sector
- RPID Health Care
- SEER Health Care
- Exchange
- RPID Nasdaq
- SEER Nasdaq
- Market Cap
- RPID 106.5M
- SEER 113.8M
- IPO Year
- RPID 2021
- SEER 2020
- Fundamental
- Price
- RPID $3.15
- SEER $2.04
- Analyst Decision
- RPID Strong Buy
- SEER
- Analyst Count
- RPID 2
- SEER 0
- Target Price
- RPID $8.00
- SEER N/A
- AVG Volume (30 Days)
- RPID 69.0K
- SEER 134.9K
- Earning Date
- RPID 10-31-2025
- SEER 11-05-2025
- Dividend Yield
- RPID N/A
- SEER N/A
- EPS Growth
- RPID N/A
- SEER N/A
- EPS
- RPID N/A
- SEER N/A
- Revenue
- RPID $30,289,000.00
- SEER $16,288,000.00
- Revenue This Year
- RPID $16.63
- SEER $27.77
- Revenue Next Year
- RPID $21.98
- SEER $20.28
- P/E Ratio
- RPID N/A
- SEER N/A
- Revenue Growth
- RPID 22.57
- SEER 10.52
- 52 Week Low
- RPID $0.83
- SEER $1.62
- 52 Week High
- RPID $4.50
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- RPID 59.08
- SEER 46.20
- Support Level
- RPID $2.63
- SEER $1.97
- Resistance Level
- RPID $3.11
- SEER $2.10
- Average True Range (ATR)
- RPID 0.21
- SEER 0.05
- MACD
- RPID 0.10
- SEER 0.00
- Stochastic Oscillator
- RPID 71.23
- SEER 43.75
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.